“Defibrillation testing can be safely omitted after S-ICD implantation when guided by the PRAETORIAN score,” Knops concluded, ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...
A 7-month-old baby squealed with laughter as his father lifted him toward a wind chime hanging from the front porch of the ...
Columbus Regional Health is pleased to offer the OmniaSecure™ defibrillation lead, a novel advancement in transvenous ...
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...
A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...
May 7 (Reuters) - Boston Scientific has issued an urgent recall to correct several heart devices after the U.S. Food and Drug ...
Objectives To identify whether patients with arrhythmia, heart failure or ischaemic heart disease presenting with anxiety ...
For the 2026/27 tax year, the maximum Personal Independence Payment (PIP) is £194.60 per week.
Highest-risk classification: FDA labeled Boston Scientific’s pacemaker recall as Class I, the most serious, due to potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results